These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5704659)

  • 21. [The effect of adrenomimetic and adrenolytic substance on the motor reaction of Fasciola hepatica L].
    Tkau VI
    Med Parazitol (Mosk); 1968; 37(1):85-90. PubMed ID: 5734371
    [No Abstract]   [Full Text] [Related]  

  • 22. Resistance of Fasciola hepatica towards hexachlorophene.
    Dorsman W
    Wiad Parazytol; 1968; 14(5):631-8. PubMed ID: 5753155
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antihelminthic action of antiviral agents].
    Burtel M
    Sem Ther; 1965 Mar; 41(3):176. PubMed ID: 5878701
    [No Abstract]   [Full Text] [Related]  

  • 24. [Relation between the structure and action of new antifasciolic agents].
    Vodrázka J
    Cesk Farm; 1968 Nov; 17(9):445-7. PubMed ID: 5719819
    [No Abstract]   [Full Text] [Related]  

  • 25. [Follow-up of 23 cases of paragonimiasis treated with bithionol].
    Liao LG
    Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1984; 2(3):184. PubMed ID: 6509748
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduced reproductive potential of Fasciola hepatica surviving in cattle treated with albendazole.
    Lang BZ; Hall RF; Kirstein KW; Wescott RB
    Vet Med Small Anim Clin; 1980 Dec; 75(12):1853-7. PubMed ID: 6906899
    [No Abstract]   [Full Text] [Related]  

  • 27. Fasciola hepatica: the flukicidal effect of some anaesthetics and analgesics in common use.
    Burden DJ; Hammet NC
    Res Vet Sci; 1983 Sep; 35(2):251-2. PubMed ID: 6635348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fasciola hepatica: Surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78.
    Keiser J; Morson G
    Exp Parasitol; 2008 May; 119(1):87-93. PubMed ID: 18261730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservative management of biliary obstruction due to Fasciola hepatica.
    Mannstadt M; Sing A; Leitritz L; Brenner-Maucher K; Bogner J
    Clin Infect Dis; 2000 Nov; 31(5):1301-3. PubMed ID: 11073771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The use of antibacterial agents in pregnancy].
    Alés Reinleìn JM; Soriano Garcia F
    Minerva Med; 1980 Oct; 71(40):2951-7. PubMed ID: 7454080
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of drugs used in the control of fasciola hepatica on the level of vitamins from group B and on the histological and histochemical pictures in the internal organs of the rat. I. Hexachloroethane (C2Cl-6),1,4,2,3-chlormethylbenzene and hexachlorophene].
    Krauss S; Zalewska E; Roszkowski J
    Wiad Parazytol; 1967; 13(1):93-107. PubMed ID: 6043608
    [No Abstract]   [Full Text] [Related]  

  • 32. [Some pathomorphologic lesions caused by hexachlorparaxylol in Fasciola by the dehelminthization of sheep].
    Reznik GK
    Wiad Parazytol; 1968; 14(5):627-30. PubMed ID: 5753356
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fascioliasis].
    Suou T; Mitsuda A; Fukui A
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):496-9. PubMed ID: 10201269
    [No Abstract]   [Full Text] [Related]  

  • 34. [Seasonal incidence of fascioliasis in cattle and taeniasis in swine].
    Deryło A; Koryciak H; Szmeja D
    Wiad Parazytol; 1983; 29(3):343-9. PubMed ID: 6649640
    [No Abstract]   [Full Text] [Related]  

  • 35. The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica.
    Keiser J; Utzinger J; Tanner M; Dong Y; Vennerstrom JL
    J Antimicrob Chemother; 2006 Dec; 58(6):1193-7. PubMed ID: 17028093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative examination of toxic effect of Zanil, Bitin-S and Bayer 9015 on fasciola].
    Delak M; Magud I
    Wiad Parazytol; 1968; 14(5):659-62. PubMed ID: 5753527
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological effects of nematode FMRFamide-related peptides (FaRPs) on muscle contractility of the trematode, Fasciola hepatica.
    Marks NJ; Maule AG; Halton DW; Geary TG; Shaw C; Thompson DP
    Parasitology; 1997 Jun; 114 ( Pt 6)():531-9. PubMed ID: 9172424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica.
    Keiser J; Utzinger J; Vennerstrom JL; Dong Y; Brennan G; Fairweather I
    Trans R Soc Trop Med Hyg; 2007 Dec; 101(12):1219-22. PubMed ID: 17905370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New antimicrobial agents for use in the intensive care unit.
    Ritchie DJ; Alexander BT; Finnegan PM
    Infect Dis Clin North Am; 2009 Sep; 23(3):665-81. PubMed ID: 19665089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.